Edward Jones lifts CVS stock rating to buy, sees turnaround potential
Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...
Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
Modern Healthcare23h
Cigna plans to limit out-of-pocket drug costs for patients
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
Boston Globe: 'Knock out the middlemen' is a campaign promise Donald Trump should keep
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.